Suspected Botulism Exposure

 

 

Purpose

 

To recommend procedures for handling potential biological threats of Botulism exposure. This policy and procedure will address foodborne and possible terrorist threat.

 

Description of AgentlSyndrome

 

1.             Botulism is an infection caused by the bacteria, Clostridium botulinum, a gram positive rod, commonly found in the soil. The bacteria forms spores which allows them to survive in a dormant state until exposed to conditions that can support their growth. There are seven types of botulism toxins designated by the letters A through G. Only types A, B, E and F are capable of causing illness in humans.

 

 

2.             Botulism is a muscle paralyzing disease, described as three types:

 

a)    Foodborne botulism: Occurring when a person ingests preformed toxin that leads to illness within a few hours to days. Foodborne botulism is a public health emergency since the contaminated source may be available for other persons besides the patient.

 

b)    Infant botulism: Occurring in a small number of susceptible infants each who harbor the organism in the intestinal tract

 

c)    Wound Botulism: Occurring when wounds are infected with the organism that secretes the toxin.

 

3.             Possible terrorist threat:

 

a)    Inhalation

 

b)         Waterborne

No instances of waterborne botulism have ever been reported. It is unlikely for at least 2 reasons. First, botulinum toxin is rapidly inactivated by standard potable water treatments (e.g., chlorination, aeration). Second, because of the slow turnover time of large-capacity reservoirs, a comparably large (and technically difficult to produce and deliver) inoculum of botulinum toxin would be needed. In contrast with treated water, botulinum toxin may be stable for several days in untreated water or beverages. Hence, such items should be investigated in a botulism outbreak if no other vehicle for toxin can be identified.

 

Transmission

 

1.             Inhalation

 

2.             Ingestion of contaminated food or water

 

Incubation

 

1.             Foodborne -

                       Neurologic symptoms of foodborne botulism begin 12—36 hours after ingestion

 

2.             Inhalation -

Neurologic symptoms of inhalational botulism begin 24—72 hours after aerosol exposure

 

Signs and Symptoms

 

1.             Double vision

2.             Blurred vision

3.             Drooping eyelids

4.             Slurred speech

5.             Difficulty swallowing

6.             Dry mouth

7.             Muscle weakness that always descends through the body: first shoulders are affected, then upper arms, lower arms, thighs, calves, etc. Paralysis of breathing muscles can cause the person to stop breathing and die unless mechanical ventilation is provided.

 

Diagnosis

 

Physicians may consider the diagnosis of botulism if the patient’s history and physical examination are consistent with the disease. However, these clues are generally not enough to allow for the diagnosis since other conditions including Guillain-Barre syndrome, stroke, and myasthenia gravis can have similar symptoms. Testing should be done to exclude these conditions, including brain scan, CSF examination, nerve conduction studies and a tensilon test to rule out myasthenia gravis. Stool samples can be tested for botulinum toxin at some state health departments or through the CDC. The local health department should be contacted to coordinate this testing.

 

Treatment

 

If diagnosed early, botulism can be treated with an antitoxin that blocks the action of the toxins circulating in the blood. This can prevent the patient from worsening, but recovery will still take several weeks. The CDC has a supply of antitoxin. If antitoxin is needed, it can be delivered to a physician anywhere in the country. Local health departments should be contacted regarding this. Most patients generally recover after weeks to months of supportive care. Ventilatory support may be necessary if respiratory paralysis occurs. Supportive medical and nursing care are dependent on the individual symptoms.

 

Prophylaxis

 

There is no prophylaxis for botulism. Preventative measures for foodborne cases are widely published, however, the concern for a terrorist event deals with protecting the water supply of a community for extrinsic contamination.

 

Control Measures and Decontamination

 

Standard Precautions are sufficient for patient care since person-to-person transmission has not been shown to occur. Patients with suspected botulism do not need to be isolated, but those with flaccid paralysis from suspected meningitis require droplet precautions. Routine decontamination of environmental surfaces is appropriate.

 

Notification

 

Internal:      At hospital notify______________________________

 

External:    All suspected cases of suspected botulism exposure are Class Al Reportable and should be reported immediately to the Local Health Department who will then contact the State Health Department and/or CDC.

 

Lab

 

Due to potential risks associated with handling infectious materials, laboratory testing should be the minimum necessary for diagnostic evaluation and patient care. Laboratory specimens should be placed in plastic bags that are sealed, and then transported in clearly labeled, durable, leak-proof containers directly to the specimen handling area of the laboratory. Care should be taken not to contaminate the external surfaces of the container. Lab personnel should be notified of what they are handling. Bio-Safety Level 2 should be used for handling specimens.

 

SPECIMENS

 

BOTULISM (Clostridium botulinum)

Red-Top or Gold-Top tubes (for serology)

Stool (not in transport medium)

Gastric aspirate

CSF (if meningeal signs are present)

ID Consult

Note on requisition

Possible C. botulinum exposure in an asymptomatic patient

No

No

No

No

No

Not applicable

Botulism – symptomatic

Yes

3 tubes (10cc blood/tube)

Yes

>25 g stool

Yes

Not recommended.  CSF will be normal; help R/O other causes

Yes

R/O Botulism

 

 

References

Final Bioterrorism Readiness Plan 4/13/99

2001 American Medical Association. All rights reserved.

(Reprinted) JAMA, February 28, 2001-Vol 285, No. 8

 

CDC Website

http://www.cdc.gov/ncidod/diseases/submenus/sub_botulism.htm

 

 

Note:    These are guidelines that have been developed with data available as of 3/13/02.

 

 

 

Initially Prepared by

The Akron Regional Hospital Association

Emergency Preparedness Subcommittee

August 20, 2002